Athira Pharma
ATHA
ATHA
98 hedge funds and large institutions have $68M invested in Athira Pharma in 2022 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 37 increasing their positions, 22 reducing their positions, and 28 closing their positions.
Holders
98
Holders Change
-7
Holders Change %
-6.67%
% of All Funds
1.66%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
23
Increased
37
Reduced
22
Closed
28
Calls
$13.1M
Puts
$5.04M
Net Calls
+$8.05M
Net Calls Change
-$14.3M
Top Buyers
| 1 |
RCM
1
RA Capital Management
Boston,
Massachusetts
|
$5.73M |
| 2 |
PA
2
Perceptive Advisors
New York
|
$14.6M |
| 3 |
3
Goldman Sachs
New York
|
$1.77M |
| 4 |
BBA
4
Baker Bros. Advisors
New York
|
$3.18M |
| 5 |
5
Two Sigma Investments
New York
|
$849K |
